Pharmacokinetics of tildipirosin in ewes after intravenous, intramuscular and subcutaneous administration

Juan Sebastián Galecio, Elisa Escudero, José Joaquín Cerón, Giuseppe Crescenzo, Pedro Marín

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

11 Citas (Scopus)

Resumen

A single-dose disposition kinetics for tildipirosin was evaluated in clinically healthy ewes (n = 6) after intravenous (IV), intramuscular (IM), and subcutaneous (SC) administration of a commercial formulation. Tildipirosin concentrations were determined by high-performance liquid chromatography with ultraviolet detection. Plasma concentration-time data was calculated by non-compartmental pharmacokinetic methods. The apparent volume of distribution (Vz) of tildipirosin after IV administration was 5.36 ± 0.57 L/kg suggesting a wide distribution in tissues and inside the cells. The elimination half-life (t12 λz) was 17.16 ± 2.25, 23.90 ± 6.99 and 43.19 ± 5.17 h after IV, IM and SC administration, respectively. Following IM administration, tildipirosin was rapidly absorbed (tmax = 0.62 ± 0.10 h) even to a greater extent than after SC administration. Time to reach peak concentration (tmax) and peak plasma concentrations (Cmax) differed significantly, but both parameters showed a more significant variability after SC than after IM administration. Bioavailabilities after extravascular administration were high (>70%). Therefore, given general adverse reactions that were not observed in any ewe and favourable pharmacokinetics, tildipirosin could be e_ective in treating bacterial infections in sheep.

Idioma originalInglés
Número de artículo1332
Páginas (desde-hasta)1-9
Número de páginas9
PublicaciónAnimals
Volumen10
N.º8
DOI
EstadoPublicada - ago. 2020

Huella

Profundice en los temas de investigación de 'Pharmacokinetics of tildipirosin in ewes after intravenous, intramuscular and subcutaneous administration'. En conjunto forman una huella única.

Citar esto